Physician profile
Robert E Wilson
NPI 1508854274
$6,576.14
in general payments reported to CMS, 2019-2025
30 companies · $840 in 2025
The $840 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $916 · 2021: $1,141 · 2022: $886 · 2023: $1,419 · 2024: $518 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,777.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,429.37 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $961.89 | 2019-2023 | Infinion 16, Wavewriter Alpha Prime 16 |
| Pfizer INC. | $339.00 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $313.81 | 2019-2022 | |
| Stryker Corporation | $303.23 | 2022-2025 | Mild Device Kit, Optablate, Spinejack |
| Vertos Medical, INC. | $267.66 | 2021-2023 | Mild Device Kit |
| Abbott Laboratories | $224.48 | 2019-2025 | Proclaim |
| Medtronic USA, INC. | $211.90 | 2019-2020 | |
| Mml US, INC. | $151.09 | 2024 | Reactiv8 |
| Teva Pharmaceuticals USA, INC. | $139.86 | 2020-2021 | |
| Si-Bone, INC. | $136.26 | 2024 | |
| Vertiflex, INC. | $135.90 | 2019 | |
| Averitas Pharma INC. | $135.87 | 2023-2024 | Qutenza |
| Nevro Corp. | $129.28 | 2019-2020 | |
| Grt US Holding, INC. | $103.41 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $87.59 | 2022 | |
| Spr Therapeutics, INC | $85.98 | 2023 | Sprint Pns System |
| Neuronetics, INC. | $79.66 | 2020 | |
| Scilex Pharmaceuticals INC. | $64.19 | 2019 | |
| Horizon Therapeutics Plc | $35.91 | 2021 | |
| Tersera Therapeutics LLC | $35.77 | 2019-2020 | |
| Mindray Ds USA, INC. | $35.37 | 2023 | A7 Anesthesia System |
| Abbvie INC. | $28.41 | 2021-2022 | |
| Pacira Therapeutics, INC. | $27.92 | 2020 | |
| Novus Surgical Consultants | $24.74 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.32 | 2019 | |
| Esperion Therapeutics, INC. | $20.23 | 2021 | |
| Teleflex LLC | $17.38 | 2020 | |
| Forte Bio-Pharma LLC | $13.43 | 2021 | |
| Painteq LLC | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.